Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Monday, March 6, 2017

Cannabinoids as Regulators of Neural Development and Adult Neurogenesis

It is cannabinoid based thus will never make it past our idiotic federal legislators having marijuana as a Class I drug.  I bet you have to go to Europe to try it. But ask your doctor how to take advantage of this. Bet you don't get an answer. 
http://link.springer.com/chapter/10.1007/978-3-319-49343-5_6
  • Alline C. Campos 
  • , Juan Paraíso-Luna
  • , Manoela V. Fogaça
  • , Francisco S. Guimarães
  • , Ismael Galve-Roperh
$29.95 / €24.95 / £19.95 *
Buy eBook
$189.00 / €161.19 / £115.50*
* Final gross prices may vary according to local VAT.
Get Access

Abstract

Neurogenesis plays an indispensable role in the formation of the nervous system during development. The discovery that the adult brain still maintains neurogenic niches that allow the continued production of new cells after birth has changed the field of neuroscience. It has also opened a new venue of opportunities for the treatment of central nervous system disorders related to neuronal loss. This chapter has reviewed the studies showing that genetic or pharmacological manipulation of cannabinoid receptors (CB1 and CB2) or the enzymes responsible for endocannabinoid metabolism modify/regulate cell proliferation and neurogenesis during development and in the adult brain. A better characterization of the mechanisms involved in these effects could contribute to the development of new therapeutic alternatives to neurodegenerative and psychiatric disorders.

No comments:

Post a Comment